These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29603667)

  • 1. A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes.
    Blatnik R; Mohan N; Bonsack M; Falkenby LG; Hoppe S; Josef K; Steinbach A; Becker S; Nadler WM; Rucevic M; Larsen MR; Salek M; Riemer AB
    Proteomics; 2018 Jun; 18(11):e1700390. PubMed ID: 29603667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.
    Nilges K; Höhn H; Pilch H; Neukirch C; Freitag K; Talbot PJ; Maeurer MJ
    J Virol; 2003 May; 77(9):5464-74. PubMed ID: 12692247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a naturally processed HLA-A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccination.
    Kather A; Ferrara A; Nonn M; Schinz M; Nieland J; Schneider A; Dürst M; Kaufmann AM
    Int J Cancer; 2003 Apr; 104(3):345-53. PubMed ID: 12569558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design.
    Grabowska AK; Kaufmann AM; Riemer AB
    Int J Cancer; 2015 Jan; 136(1):212-24. PubMed ID: 24824905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
    Jabbar B; Rafique S; Salo-Ahen OMH; Ali A; Munir M; Idrees M; Mirza MU; Vanmeert M; Shah SZ; Jabbar I; Rana MA
    Front Immunol; 2018; 9():3000. PubMed ID: 30619353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
    Mizuuchi M; Hirohashi Y; Torigoe T; Kuroda T; Yasuda K; Shimizu Y; Saito T; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):185-90. PubMed ID: 22032938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest China.
    Chenzhang Y; Wen Q; Ding X; Cao M; Chen Z; Mu X; Wang T
    Immunol Lett; 2017 Jan; 181():26-30. PubMed ID: 27693214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.
    Riemer AB; Keskin DB; Zhang G; Handley M; Anderson KS; Brusic V; Reinhold B; Reinherz EL
    J Biol Chem; 2010 Sep; 285(38):29608-22. PubMed ID: 20615877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
    Youde SJ; Dunbar PR; Evans EM; Fiander AN; Borysiewicz LK; Cerundolo V; Man S
    Cancer Res; 2000 Jan; 60(2):365-71. PubMed ID: 10667589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.
    Cheng WF; Lee CN; Su YN; Chang MC; Hsiao WC; Chen CA; Hsieh CY
    Immunology; 2005 May; 115(1):136-49. PubMed ID: 15819706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope.
    Alexander M; Salgaller ML; Celis E; Sette A; Barnes WA; Rosenberg SA; Steller MA
    Am J Obstet Gynecol; 1996 Dec; 175(6):1586-93. PubMed ID: 8987945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer.
    Chan PK; Liu SJ; Cheung JL; Cheung TH; Yeo W; Chong P; Man S
    J Med Virol; 2011 Jun; 83(6):1023-30. PubMed ID: 21503915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
    Dong D; Zhu Y; Aili Z; Chen Z; Ding J
    Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
    Ressing ME; van Driel WJ; Brandt RM; Kenter GG; de Jong JH; Bauknecht T; Fleuren GJ; Hoogerhout P; Offringa R; Sette A; Celis E; Grey H; Trimbos BJ; Kast WM; Melief CJ
    J Immunother; 2000; 23(2):255-66. PubMed ID: 10746552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.
    He J; Yang Y; Chen Z; Liu Y; Bao S; Zhao Y; Ding X
    Virol J; 2019 May; 16(1):72. PubMed ID: 31138240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions.
    Evans C; Bauer S; Grubert T; Brucker C; Baur S; Heeg K; Wagner H; Lipford GB
    Cancer Immunol Immunother; 1996 Mar; 42(3):151-60. PubMed ID: 8640843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
    J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells.
    Mohan N; Wellach K; Özerdem C; Veits N; Förster JD; Foehr S; Bonsack M; Riemer AB
    Front Immunol; 2022; 13():918528. PubMed ID: 36341354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.
    Höhn H; Pilch H; Günzel S; Neukirch C; Freitag K; Necker A; Maeurer MJ
    J Virol; 2000 Jul; 74(14):6632-6. PubMed ID: 10864677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.